Life at the Johns Hopkins School of Medicine
Luis Monsalve, graduate of the Bloomberg School of Public Health, gives a firsthand look into his experiences working on Pfizer’s COVID-19 vaccine trial and his new role in vaccine distribution with Jhpiego.
Like most front-line health care workers, resident Mark Lieber is now fully vaccinated against COVID-19. He discusses why he’s still wearing a mask.
The COVID-19 vaccine campaign will last for months, if not longer — it took over a hundred years for vaccination to wipe out smallpox. By examining how smallpox vaccination succeeded and failed, we can learn what may happen with the COVID-19 vaccine rollout and how to address potential pitfalls.
With cold and flu season fast approaching, the push to vaccinate communities against influenza is greater than ever. Meanwhile, COVID-19 vaccine trials are working furiously to release a winning candidate by the end of the year.
Dengue, a virus endemic to Latin America and Southeast Asia, infects about 400 million people and causes about 25,000 deaths each year by dengue hemorrhagic… Read More »The Dengue Vaccine Controversy Explained
On the Johns Hopkins “Measles: What You Should Know” page, the last Q&A states: Q: What should I do to protect myself and my family?… Read More »An Evolving Situation: Measles and the 21st Century Vaccination Crisis
I was first offered the HPV vaccine during my college years. Although I had been counseled about the importance of the vaccine at that time,… Read More »Vaccination Woes: HPV Vaccination Rates Remain Low
I was not surprised to learn that Baltimore ranks higher than the national average in cervical cancer incidence. In my few years of residency, I… Read More »Johns Hopkins Physician Finds Efficacy in Cervical Cancer Vaccine